China At Forefront Of Next Generation Sequencing: BGI CEO
This article was originally published in PharmAsia News
From screening for cancer to providing individualized treatment, from rare diseases to the first in vitro fertilized (IVF) baby with modified genes, China has much to offer in the heating global race for next generation gene sequencing. Big data and the internet of genomics are just some examples, says Wang Jun, CEO of BGI, the world’s largest genomics organization.
You may also be interested in...
Junshi’s oral antiviral shows signs of effectiveness in treating patients with mild COVID-19 symptoms but more data are needed, caution researchers.
2021 saw a record number of novel drug launches and the size of the pipeline topped 20,000 candidates for the first time, new analysis shows, while China came of age as a pharma player.
Important changes are coming to China's Drug Administration Law as the government aims to address through several revisions a number of key issues since the law’s original enactment in 2019.